Huls G, Chitu D, Havelange V, et al. Randomized Maintenance Therapy with Azacitidine (Vidaza) in Older Patients (≥ 60 years of age) with Acute Myeloid Leukemia (AML) and Refractory Anemia with Excess of Blasts (RAEB, RAEB-t). Results of the HOVON97 Phase III Randomized Multicentre Study (EudraCT 2008-001290-15). ASH 59th Annual Meeting & Exhibition, abstract 463.
T-cellymfoom na CAR T-celtherapie zeldzaam; genetische modificatie van cellen niet altijd de oorzaak
nov 2024 | Lymfoom